BODENSTEDT MATTHIAS (Chief Financial Officer) sold 0.2% of their position (2.43K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $47.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/16/2026ACC: 0001213900-26-044642
Officer· Chief Financial Officer
Since Apr 2022
-2.43K
Net shares
Net seller
$47.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.43K disposed
Non-Derivative Transactions1
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−2.43K
Price / share
$19.56
Trade value
$47.45K
% of position
0.2%
4/14/2026
1.19M→1.19M
Total
Net shares
−2.43K
Net value
-$47.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 4/14/2026 | S · Sale | −2.43K | $19.56 | $47.45K | 0.2% | 1.19M | 1.19M |
| Total | −2.43K | -$47.45K | ||||||
Derivative Transactions0
No derivative transactions reported